Zobrazeno 1 - 10
of 393
pro vyhledávání: '"de Scheerder I"'
Publikováno v:
In Journal of Pharmaceutical Sciences December 2008 97(12):5047-5060
Autor:
de Scheerder, I.1, Vandekerckhove, J.2, de Schrijver, G.3, Hoste, M.1, Clement, D.1, Wieme, R.3, Pannier, R.1
Publikováno v:
Clinical & Experimental Immunology. May1985, Vol. 60 Issue 2, p403-406. 4p.
Autor:
de Scheerder, I.1, Wulfrank, D.1, van Renterghem, L.1, Sabbe, L.1, Robbrecht, D.1, Clement, D.1, Derom, F.1, Plum, J.1, Verdonk, G.1
Publikováno v:
Clinical & Experimental Immunology. Aug1984, Vol. 57 Issue 2, p423-428. 6p.
Autor:
Foley, DP, Pieper, M, Wijns, W, Suryapranata, H (Harry), Grollier, G, Legrand, V, De Scheerder, I, Hanet, C, Puel, J, Mudra, H, Bonnier, JJRM, Colombo, A, Thomas, M, Probst, P, Morice, MC, Kleijne, J, Serruys, PWJC (Patrick), MAGIC 5L Investigators,
Publikováno v:
European Heart Journal, 22, 1585-1593. Oxford University Press
Aims To prospectively evaluate the influence of stent length on 6 month clinical and angiographic outcome, in patients with native coronary lesions up to 45mm in length, undergoing elective Magic Wallstent implantation. Methods and Results On the bas
Publikováno v:
Tijdschrift voor Geneeskunde. 54:585-593
Autor:
Kaluza, G.L., Gershlick, A.H., Park, S.J., de Scheerder, I., Chevalier, B., Camenzind, E., Goy, J.J., Missault, L., Reifart, N., Vrints, Christiaan, Urban, P., Shim, W.H., Ho, D.S., Fearnot, N.E., Voorhees, W.D., Raizner, A.E.
Publikováno v:
The American journal of cardiology
Autor:
De Scheerder I, Legrand, P. Lafontaine, Claude Hanet, J. Boland, Edouard Benit, P. Materne, William Wijns, M. Vrolix, Marc J. Claeys, Vandenbranden F, C.J. Vrints, Y. Taeymans, Eemans T, Gr. Heyndrickx
Publikováno v:
Acta cardiologica
More than 20.000 percutaneous coronary interventions (PCI) procedures are performed yearly in Belgium. The success of new coronary devices as well as the expanded indications, notably in acute coronary syndromes, suggest a continuous increase in perc
Autor:
Salu, K., Bosmans, J., Huang, Y., Hendriks, M., Verhoeven, M., Levels, A., Liu, X., de Scheerder, I., Bult, H., Vrints, C.
Publikováno v:
5th International Congress on Coronary Artery Disease, OCT 19-22, 2003, FLORENCE, ITALY
Frontiers in coronary artery disease
Frontiers in coronary artery disease
This study evaluates the efficacy of 20mg cytochalasin D- (CD, an actin-filament inhibitor) eluting, polymer-coated stents on in-stent neointima formation in a porcine coronary model. In vitro release in Tris buffer at 37degreesC was 22% after 24 hou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2097::8d4d2231eda4174ed18de7fa1c51771a
https://hdl.handle.net/10067/1038510151162165141
https://hdl.handle.net/10067/1038510151162165141
Autor:
De Scheerder I, K, Wang, X R, Zhou, E, Verbeken, Q B, Ping, H, Yanming, H, Jianhua, M, Szilard, Van de Werf F
Publikováno v:
The Journal of invasive cardiology. 11(1)
Although coronary stenting has been demonstrated to significantly reduce restenosis compared to conventional angioplasty, occurrence of in-stent stenosis still remains one of the major limitations. This study investigates the influence of stent strut
Autor:
De Scheerder I, Wilczek, Van Dorpe J, Verbeken, Cathapermal, Wang, Desmet, Schacht, Foegh, De Geest H, Piessens
Publikováno v:
The Journal of invasive cardiology. 8(5)
BACKGROUND: Systemic administration of angiopeptin has been shown to inhibit myointimal thickening after arterial injury in several animal species. METHODS AND RESULTS: To explore to what extent high and long-lasting local concentrations of angiopept